U.S., June 11 -- An application to own the trademark for 'ZOLGENSMA INTRATHECAL' has been filed on Apr. 01, 2025.
Owner(s):
Novartis AG; CH-4002, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containin...